Dr. Naismith is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
517 S Euclid Ave
Saint Louis, MO 63110Phone+1 314-362-3293Fax+1 314-747-1345- Is this information wrong?
Education & Training
- Washington University/B-JH/SLCH ConsortiumResidency, Neurology, 2000 - 2003
- Washington University/B-JH/SLCH ConsortiumResidency, Internal Medicine, 1998 - 2000
- Case Western Reserve University School of MedicineClass of 1998
Certifications & Licensure
- IL State Medical License 2021 - 2026
- MO State Medical License 2000 - 2025
- FL State Medical License 2019 - 2021
- American Board of Psychiatry and Neurology Neurology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification Allscripts Enterprise EHR, Allscripts, 2012
Clinical Trials
- Ampyra for Optic Neuritis in Multiple Sclerosis Start of enrollment: 2011 May 01
- Safety, Tolerability and Activity Study of Ibudilast in Subjects With Progressive Multiple Sclerosis Start of enrollment: 2013 Nov 01
- Effect of MD1003 in Progressive Multiple Sclerosis (SPI2) Start of enrollment: 2016 Dec 01
Publications & Presentations
PubMed
- Structural MRI measures are associated with fatigue severity and persistence in a large, real-world cohort of people with multiple sclerosis.Chen Hu, Kathryn C Fitzgerald, Alexandra C Simpson, Ellen M Mowry, Robert T Naismith, Bardia Nourbakhsh> ;Multiple Sclerosis. 2024 Mar 25
- Diffusion basis spectrum imaging and diffusion tensor imaging predict persistent black hole formation in multiple sclerosis.Lindsey Wooliscroft, Amber Salter, Gautam Adusumilli, Victoria A Levasseur, Peng Sun, Samantha Lancia, Dana C Perantie, Kathryn Trinkaus, Robert T Naismith, Sheng-Kwei...> ;Multiple Sclerosis and Related Disorders. 2024 Apr 1
- Concurrent administration of serotonergic antidepressants and ozanimod in participants with relapsing multiple sclerosis from the open-label extension DAYBREAK trial.Comi, G., Selmaj, K., Hartung, H., Sheffield, J., Krakovich, A., Tatosian, D., Cheng, C., Reardon, J., Khaychuk, V., Riolo, J., Silva, D., Naismith, R., Cohen, J., Bar...> ;Multiple Sclerosis. 2024 Feb 1
- Join now to see all
Journal Articles
- Turning Is an Important Marker of Balance Confidence and Walking Limitation in Persons with Multiple SclerosisRobert Naismith, MD, PLoS One
Press Mentions
- NIH STTR Grant to Fast Track New Class of Pain Reliever Without Addiction or ToxicityOctober 21st, 2020
- Oral Vumerity Easier on Gastrointestinal Tract Than Tecfidera, Phase 3 Trial FindsAugust 1st, 2019
- Ibudilast Slows Brain Shrinkage in Progressive Multiple SclerosisAugust 31st, 2018
- Join now to see all
Grant Support
- Diffusion Imaging Of Axonal Loss In The Optic NervesNational Institute Of Neurological Disorders And Stroke2007–2011
Hospital Affiliations
- Barnes-Jewish HospitalSaint Louis, Missouri
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: